Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The record history dates shift from May 2026 to November 2026, reflecting a newer administrative update to the study record.
    Difference
    0.2%
    Check dated 2026-11-14T23:38:35.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record for nivolumab and radiation therapy, with or without ipilimumab, is now displayed instead of an error page. It provides details about the trial’s design, eligibility criteria, outcome measures, and study location.
    Difference
    74%
    Check dated 2026-11-08T03:12:14.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T23:13:37.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T23:11:17.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T23:36:23.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-10T23:27:27.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.